BTG PLC
| Use attributes for filter ! | |
| Stock price | BTG |
|---|---|
| Disclaimer | |
| Headquarters | London |
| United Kingdom | |
| Ceo | Louise Makin |
| Revenue | 620. 5 million GBP (2018) |
| Subsidiaries | Biocompatibles |
| Galil Medical Ltd. | |
| Protherics Inc. | |
| Date of Reg. | |
| Date of Upd. | |
| ID | 1069556 |
About BTG PLC
BTG plc is an international specialist healthcare company that is developing and commercialising products targeting critical care, cancer and other disorders. The current name was adopted when the British Technology Group changing its name on 27 May 1998. BTG is a constituent of the FTSE 250 Index.
